PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3826 (102nd)

Medicare Cancer Coverage Improvement Act of 1991

referredUnited States· United States Congress· EN

Introduced

20 November 1991

Last action

14 January 1992 · Referred

Status

Referred to the Subcommittee on Health and the Environment.

Sponsors

SANDER LEVIN, Sen. Durbin, Richard J. [D-IL], Rep. Evans, Lane [D-IL-17], Rep. Jefferson, William J. [D-LA-2], Rep. Kolter, Joseph P. [D-PA-4], Rep. Mrazek, Robert J. [D-NY-3], Del. Norton, Eleanor Holmes [D-DC-At Large], Nancy Pelosi, Rep. Rangel, Charles B. [D-NY-19], Harold Rogers, Rep. Vento, Bruce F. [D-MN-4], Rep. Frost, Martin [D-TX-24], Rep. Lehman, William [D-FL-13], NITA LOWEY, Rep. McDermott, Jim [D-WA-7], Rep. Coleman, Ronald D. [D-TX-16], Rep. Dwyer, Bernard J. [D-NJ-6], Rep. Horton, Frank J. [R-NY-34], Rep. Jontz, Jim [D-IN-5], Rep. Kildee, Dale E. [D-MI-7], Rep. Kopetski, Mike [D-OR-5], Rep. Moran, James P. [D-VA-8], Rep. Oberstar, James L. [D-MN-8], Rep. Roe, Robert A. [D-NJ-8], LOUISE SLAUGHTER, Rep. Smith, Lawrence [D-FL-16], Sen. Markey, Edward J. [D-MA], Rep. Lancaster, H. Martin [D-NC-3], Rep. Foglietta, Thomas M. [D-PA-1], Rep. Moody, Jim [D-WI-5], JOSE SERRANO, Rep. Towns, Edolphus [D-NY-11], Rep. Boxer, Barbara [D-CA-6], Rep. Dicks, Norman D. [D-WA-6], Rep. Erdreich, Ben [D-AL-6], Rep. Fish, Hamilton, Jr. [R-NY-25], Rep. Jacobs, Andrew, Jr. [D-IN-11], Rep. Johnson, Tim [D-SD-At Large], Rep. Panetta, Leon [D-CA-16], Rep. Sangmeister, George E. [D-IL-4], Rep. Schiff, Steven [R-NM-1], Rep. Borski, Robert A. [D-PA-3], Rep. Bereuter, Doug [R-NE-1], Rep. Collins, Barbara-Rose [D-MI-15], Rep. Dixon, Julian C. [D-CA-28], Rep. English, Glenn [D-OK-6], Rep. Martinez, Matthew G. [D-CA-30], Rep. McCloskey, Frank [D-IN-8]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

Medicare Cancer Coverage Improvement Act of 1991 - Amends title XVIII (Medicare) of the Social Security Act to cover: (1) any use of a drug in an anticancer chemotherapeutic regimen if such use has been approved by the Food and Drug Administration, published in peer-review medical literature, or included in one or more of three specified medical compendia; and (2) an oral form of a drug prescribed for such a use in an anticancer chemotherapeutic regimen if the drug contains the same active ingredients as a drug that would be covered if administered as incident to a physician's service. Requires a study and report to specified congressional committees on Medicare coverage of patient care costs associated with clinical trials of new cancer therapies.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 20 November 1991

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 20 November 1991

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 20 November 1991

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 25 November 1991

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 14 January 1992

    Referred

    Referred to the Subcommittee on Health and the Environment.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

2 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 55 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.